The Less is More Study

NCT05153811 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-07-31

No results posted yet for this study

Summary

In this project, the investigators will implement innovations to extend use of Contingency Management (CM) to facilitate alcohol use reduction among people living with HIV (PLWH). The investigators' approach to extending CM will use mobile health (mHealth) tools including a smartphone breathalyzer device with accompanying app and a wrist worn alcohol biosensor. Participants will be engaged in mobile facilitated CM for 30-60 days with follow-up out to 6 months.

Conditions

  • Alcohol Use

Interventions

BEHAVIORAL

Counseling

Brief counseling including personalized feedback on breath alcohol concentration, cognitive task performance and physical functioning

BEHAVIORAL

mHealth

Participants will engage with an application designed to gamify drinking reduction.

BEHAVIORAL

Counseling

Brief counseling including personalized feedback on breath alcohol concentration, cognitive task performance and physical functioning.

Sponsors & Collaborators

  • University of Miami

    collaborator OTHER
  • University of Louisville

    collaborator OTHER
  • Florida State University

    collaborator OTHER
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH
  • University of Florida

    lead OTHER

Principal Investigators

  • Robert Leeman, Ph.D · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-10
Primary Completion
2026-09-01
Completion
2026-09-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05153811 on ClinicalTrials.gov